FDA Orange Book · active-ingredient family
Ciclesonide
Ciclesonide is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ZETONNA · NDA 202129
3
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · aerosol, metered, spray, metered
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZETONNARLD | AZURITY | NDA 202129 | — | Jan 20, 2012 | |
| ALVESCORLD×2 | COVIS | NDA 021658 | — | Jan 10, 2008 | |
| OMNARISRLD | AZURITY | NDA 022004 | — | Oct 20, 2006 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8371292 | Feb 01, 2028 | in 1 yr 8 mo | U-1355 |
Ciclesonide — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
